KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Other Accumulated Expenses (2020 - 2025)

Oscar Health (OSCR) has disclosed Other Accumulated Expenses for 6 consecutive years, with $1.5 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Accumulated Expenses rose 7.27% year-over-year to $1.5 billion, compared with a TTM value of $1.5 billion through Dec 2025, up 7.27%, and an annual FY2025 reading of $1.5 billion, up 7.27% over the prior year.
  • Other Accumulated Expenses was $1.5 billion for Q4 2025 at Oscar Health, down from $1.6 billion in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $1.6 billion in Q3 2025 and bottomed at $358.1 million in Q1 2021.
  • Average Other Accumulated Expenses over 5 years is $1.0 billion, with a median of $960.0 million recorded in 2023.
  • The sharpest move saw Other Accumulated Expenses skyrocketed 116.17% in 2022, then fell 8.57% in 2023.
  • Year by year, Other Accumulated Expenses stood at $513.6 million in 2021, then skyrocketed by 82.59% to $937.7 million in 2022, then increased by 3.01% to $966.0 million in 2023, then soared by 40.45% to $1.4 billion in 2024, then rose by 7.27% to $1.5 billion in 2025.
  • Business Quant data shows Other Accumulated Expenses for OSCR at $1.5 billion in Q4 2025, $1.6 billion in Q3 2025, and $1.6 billion in Q2 2025.